Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Exchange Rate Effect (2016 - 2025)

Haemonetics (HAE) has 17 years of Exchange Rate Effect data on record, last reported at $810000.0 in Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 113.04% year-over-year to $810000.0; the TTM value through Dec 2025 reached $7.0 million, up 213.53%, while the annual FY2025 figure was -$685000.0, 78.49% up from the prior year.
  • Exchange Rate Effect reached $810000.0 in Q4 2025 per HAE's latest filing, up from -$773000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $4.6 million in Q4 2022 and bottomed at -$6.2 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is -$423400.0, with a median of -$720000.0 recorded in 2021.
  • The widest YoY moves for Exchange Rate Effect: up 1053.44% in 2022, down 1631.68% in 2022.
  • A 5-year view of Exchange Rate Effect shows it stood at -$667000.0 in 2021, then surged by 784.71% to $4.6 million in 2022, then plummeted by 33.85% to $3.0 million in 2023, then tumbled by 305.63% to -$6.2 million in 2024, then soared by 113.04% to $810000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $810000.0 in Q4 2025, -$773000.0 in Q3 2025, and $4.2 million in Q2 2025.